Search

everythinglearnresearchcommunity

for

Search:↓

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Minoxidil helps hair regrowth in traction alopecia.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

A woman with severe angioedema improved significantly after treatment with rituximab.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Effective symptom management in IBD improves quality of life and prevents complications.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.